Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$98.32 USD

98.32
21,578,090

-0.84 (-0.85%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $98.81 +0.49 (0.50%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 43% (106 out of 247)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Moumi Mondal headshot

CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount

by Moumi Mondal

CVS trims its outlook as Oak Street faces rising medical costs, but new leadership and tech upgrades aim for steady growth.

Moumi Mondal headshot

CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention?

by Moumi Mondal

CVS shows revenue growth and raised guidance, while EVH faces revenue declines but pursues oncology deals and efficiency gains.

Zacks Equity Research

Danaher's Life Sciences Segment Shrinks: What's the Path Forward?

by Zacks Equity Research

DHR's Life Sciences unit faces revenue declines from weak demand, but new products and biotech advances offer growth potential.

Zacks Equity Research

CVS Health (CVS) Stock Dips While Market Gains: Key Facts

by Zacks Equity Research

CVS Health (CVS) reached $73.5 at the closing of the latest trading day, reflecting a -1.98% change compared to its last close.

Zacks Equity Research

Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?

by Zacks Equity Research

DHR's Biotechnology unit grows 6% in Q2, driven by bioprocessing, despite weakness in research equipment demand.

Zacks Equity Research

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Moumi Mondal headshot

CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?

by Moumi Mondal

CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.

Kaibalya Pravo Dey headshot

UnitedHealth Finds Its Stars, Soars 8.6% as Humana Trips on Cut Points

by Kaibalya Pravo Dey

UNH surges 8.6% as it projects stable Medicare Advantage star ratings, easing investor worries over performance.

Zacks Equity Research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Wall Street Analysts See CVS Health (CVS) as a Buy: Should You Invest?

by Zacks Equity Research

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?